Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New booklet provides update on equine grass sickness
The booklet aims to improve understanding of the incidence and risk factors associated with the disease.

Publication brings together the latest research.

A new booklet highlighting the vital role owners can play in reporting equine grass sickness (EGS) has been published by the Moredun Research Institute.

The booklet, entitled Equine Grass Sickness: A Research Update and Look to the Future, also aims to improve understanding of the incidence and risk factors associated with the disease.

It has been compiled in collaboration with the University of Edinburgh, the EGSF, University of Liverpool, British Horse Society and World Horse Welfare (WHW).

Roly Owers from WHW said “Equine grass sickness is a truly horrible disease that all too often impacts World Horse Welfare directly, with one of our Rescue and Rehoming Centres being in Aberdeenshire and another in Norfolk, both areas with a high EGS prevalence It is a disease that has been known about for decades yet there is still so much we don’t know about it.

“We are pleased to support this publication bringing together the latest information about this pernicious and stubbornly mysterious disease and to work with EGSF in their determination to increase our understanding of it and to find a cure for it.”

Moredun began researching into EGS in the 1920s when the disease caused the deaths of many working horses on farms. One-hundred years later, the disease continues to elude researchers, but the consensus is that it is likely to be caused by numerous factors.

There are no treatments or vaccines to prevent EGS, and around 80 per cent of horses that contract the disease do not survive. It is strongly linked to the east of the UK, with Aberdeenshire being the county suffering the most cases annually in the UK.

EGS also has a seasonal pattern and is most common in the spring, early summer and in young, adult equines.

Helene Mauchlen, from BHS Scotland, commented: “We are delighted to support this research update, which is a useful summary of exactly where we are with this complex and destructive disease, showcasing decades of work and signposting us to a better and hopefully EGS-free future”.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.